Alkenes are industrially important platform chemicals with broad applications. In this 24 study, we report a microbial conversion route for direct biosynthesis of medium and long chain 25 terminal alkenes from fermentable sugars by harnessing a novel P450 fatty acid (FA) 26 decarboxylase from Macrococcus caseolyticus (OleTMC). We first characterized OleTMC and 27 demonstrated its in vitro H2O2-independent activities towards linear and saturated C10:0-C18:0 28 FAs, with the highest activity for C16:0 and C18:0 FAs. Combining protein homology 29 modeling, in silico residue mutation analysis, and docking simulation with direct experimental 30 evidence, we elucidated the underlying mechanism for governing the observed substrate 31 preference of OleTMC, which depends on the size of FA binding pocket, not the catalytic site. 32
Alkenes (or olefins) are industrially important platform chemicals used to manufacture 52 polymers, lubricants, surfactants, and coatings (1). Alkenes are currently produced by the well-53 established chemical conversion route (e.g., hydrogen cracking) using petroleum-based 54 feedstocks that are neither renewable nor sustainable (2, 3). In recent years, there is great 55 interest in developing microbial conversion routes to produce alkenes from renewable and 56 sustainable sources, such as biomass-derived fermentable sugars (4-10). 57
Various species are known to produce alkenes endogenously via decarbonylation of 58 aldehydes (11-13), decarboxylation of FAs (14), condensation of unsaturated polyenes (15), 59 and oxidation of FAs (7, 8) . Various types of alkenes can be synthesized including alkadienes 60 (16, 17), terminal alkenes (or 1-alkenes) (4, 6-8) as well as non-terminal alkenes (5), depending 61 on enzyme types and substrates employed. To date, a number of different classes of enzymes 62 have been reported to synthesize terminal alkenes including a P450 FA 63 decarboxylase/peroxygenase (OleT, belonging to the CYP152 family) (4), a type-I polyketide 64 synthase-like enzyme (CurM/Ols) (6), a desaturase-like enzyme (UndB) (7), and a non-heme 5 FA in the presence of redox partner proteins and C14:0 FA in the H2O2−dependent system (16) . 76
For the low-cost, large-scale production of terminal alkenes, the use of H2O2-independent 77 decarboxylases (e.g., OleTJE) is likely favorable by avoiding the external supply and 78 cytotoxicity of H2O2. Thus, harnessing the enzyme library of H2O2−independent 79 decarboxylases are important for the microbial production of terminal alkenes from biomass-80 derived sugars. 81
In this study, we expanded the library of unique OleTs for terminal alkene biosynthesis 82 by characterizing a novel P450 FA decarboxylase OleTMC derived from Macrococcus 83 caseolyticus for its catalytic functions. We employed protein homology modeling, in silico 84 residue mutation analysis, and docking simulation to elucidate the underlying mechanism of 85 fatty acid specificity of OleTMC. Furthermore, we harnessed this OleTMC to engineer a terminal 86 alkene biosynthesis pathway in E. coli for direct conversion of fermentable sugars into medium 87 and long chain terminal alkenes (Figure 1 ). We discovered that electron transfer was the rate 88 limiting step of alkene biosynthesis in the recombinant E. coli. This limitation could be 89 alleviated by expressing the redox system CamA/B from Pseudomonas putida in the 90 recombinant E. coli, resulting in enhanced alkene production. 91 92 2. RESULTS AND DISCUSSION 93
Genome mining of OleT decarboxylases for terminal alkene biosynthesis 94
To identify the putative H2O2-independent P450 FA decarboxylases, we performed a genome 95 mining, a combination of the sequence alignment and phylogenetic analysis, using the protein 96 sequence of OleTJE (ADW41779) as a template. The sequences of the CYP152 P450 enzyme 97 family (4) were first aligned to select the candidates that have the conserved catalytic site 98 residues Phe79, His85, and Arg245 like OleTJE (20). Among the 29 decarboxylase candidates, 99 we found that three P450 enzymes from M. caseolyticus (WP_041635889.1), Corynebacterium 100 7 Currently, it is not well understood why different FA decarboxylases have different 126 substrate specificities. For instance, OleTJE prefers C12:0-C14:0 FAs to longer ones (16, 20) 127 while OleTMC favors C16:0-C18:0 FAs more than shorter ones (this study). To better 128 understand the underlying mechanism for governing the observed substrate preference of 129
OleTMC, we focused on analyzing its protein structure, using protein homology modeling, in 130 silico residue mutation analysis, and docking simulation in combination with direct 131 experimental evidence. 132 133
Analysis of the effect of catalytic site on the substrate specificity of OleT MC. 134
Since OleTMC and OleTJE have different substrate preferences, we first tested whether structural 135 difference of their catalytic sites might exist and play a role. To do this, we built a 3D structure 136 of OleTMC using the version 2015.10 Molecular Operating Environment (MOE) software (21), 137 based on the best-hit crystallographic structure of the substrate-bound (C20:0, arachidic acid) 138 form of OleTJE (PDB:4L40 (19), ~60% amino acid identity) as a template. The Ramachandran 139 plot of OleTMC showed less than 0.5% of the residues to be in disallowed regions 140 (Supplementary Figure S4 ). Next, we superposed the heme-bound 3D structures of OleTMC and 141 OleTJE and found that they look almost identical ( Figure 4A ) with a very similar catalytic site 142 configuration ( Figure 4B shorter chain FAs ( Figure 3B ). Remarkably, there is a strong linear correlation (R 2 = 0.92) 158 between the binding free energies and specific activities of OleTMC for various FAs ( the substrate specificity of OleTMC, we first performed the alanine scan using the "alanine scan" 164 tool in MOE. We scanned a set of 21 residues located at the FA docking sites of FA-bound 165
OleTMC complexes (Supplementary Figure S5A ) by substituting each candidate with Ala 166 residue. Regardless of C10:0-C18:0 FAs, we found that the mutation at P72A or I171A 167 increased the stability, while F174A or F296A decreased the stability ( Figure 3D ). In contrast, 168 the mutation at I177A or V294A showed different stabilities for different FAs. Based on this 169 first round of alanine scan and stability analysis, we narrowed the initial large set of 21 170 candidate residues to the 6 promising candidates, including P72, I171, F174, I177, F296 or 171 V294, that might have a significant role for the substrate specificity of OleTMC. 172
Next, we performed a comprehensive residue scan for these 6 candidate residues using 173 the "residue scan" tool in MOE. Specifically, we generated a set of 54 OleTMC variants by glycine (Gly, G), Ala, Val, Leu, Ile, Pro, Phe, methionine (Met, M), and tryptophan (Trp, W) and performed the stability analysis ( Supplementary Figures S7A-F) . By determining the 177 largest △stability differences between C18:0 FA-bound and C10:0 FA-bound OleTMC 178 complexes for each OleTMC variant, we could select a list of the top five mutants, including 179 I177W, P72M, F296W, I177F, and P72F (Supplementary Figure S7G ), for detail structure 180 analysis. Interestingly, all these five OleTMC variants, selected by combination of alanine and 181 residue scans, had the mutated residues located at the tail of the FA binding pocket (Figures 182
4C-4H). 183
To determine whether the top 5 OleTMC variants are responsible for substrate 184 preferences of OleTMC, we next generated their 3D structures in MOE, followed by docking 185 simulation of these variants with various FAs (C10:0-C18:0). Our result shows that the two 186 variants, OleTMC P72M and F296W, significantly shifted substrate preferences while the other 187 variants, OleTMC I177W, I177F, and P72F, did not ( Figure 4B ). For the OleTMC F296W model, 188
we observed that the correct docking poses, whose Arg246 should interact with the carboxylic 189 functional group of FAs via hydrogen bonding, were no longer detected with C16:0 and C18:0 190
FAs. It has the lowest Gbind of -8.43 kcal/mol with C14:0 FA and the highest Gbind of -6.72 191 kcal/mol with C10:0 FA. Likewise, OleTMC P72M showed the lowest Gbind of -8.23 kcal/mol 192 with C14:0 FA and the highest Gbind of -6.18 kcal/mol with C18:0 FA. These results suggest 193 that P72M and F296W variants can shift the substrate preferences from longer to shorter FAs. 194 195 
Reconfiguration of the binding pocket is responsible for shifting the substrate

Establishing the terminal alkene biosynthesis pathway in E. coli 211
We designed the heterologous terminal alkene biosynthesis pathway in E. coli BL21 (λDE3), 212 consisting of two genes − the leaderless tesA* gene encoding a thioesterase to convert acyl 213
ACPs to FAs and the OleTMC gene encoding a decarboxylase to convert these FAs to terminal 214 alkenes. We chose TesA* because it has higher specificities towards C16:0-C18:0 acyl ACPs 215 than C12:0-C14:0 acyl ACPs (25) to produce corresponding FAs that are preferable substrates 216 for OleTMC. Figure Figure 5A ). Terminal alkene production peaked at a 222 titer of 21.92 ± 0.69 mg/L, comprised of 4.5% ± 0.2% C11 alkene, 38.9% ± 1.1% C13 alkene, 223
55.4% ± 0.8% C15 alkene, and 1.2% ± 0.5% C17 alkene ( Figure 5B ). Besides alkenes, the 224 corresponding FAs were also produced at a much higher titer of 558.03 ± 18.95 mg/L, 225 consisting of 24.9% ± 0.1% C12:0 FA, 41.0% ± 0.2% C14:0 FA, 25.2% ± 0.4% C16:0 FA, 226 7.6% ± 0.3% C18:0 FA, and 1.4% ± 0.1% C20:0 FA ( Figure 5C ). The composition of these 227
FAs correlated well with the specificity of TesA* (25). The relatively high FA production 228 clearly implied that OleTMC was the rate-limiting step of the engineered terminal alkene 229 biosynthesis pathway. The result also shows that the C15 alkene was produced at the highest 230 level even though the fraction of C16:0 FA was lower than that of C14:0 FA and relatively 231 similar to that of C12:0 FA. This result is consistent with the substrate preference of OleTMC 232 towards C16:0 FA characterized in vitro and also implies that C16:0 FA was not limiting for alkenes produced by EcNN201 comprised of 2.4% ± 1.5% C11 alkene, 32.1% ± 5.8% C13 261 alkene, 64.3% ± 6.7% C15 alkene, and 1.2% ± 0.3% C17 alkene. Like EcNN101, EcNN201 262 produced a high amount of saturated FAs (556.12 ± 4.44 mg/L) consisting of 17.3% ± 0.3% 263 C12:0 FA, 40.0% ± 0.5% C14:0 FA, 33.3% ± 0.3% C16:0 FA, 7.8% ± 0.4% C18:0 FA, and 264
1.6% ± 0.3% C20:0 FA ( Figure 5F ). Overall, the terminal alkene production phenotypes were 265 similar between EcNN101 and EcNN201 during the growth phase. This result implies that 266 reducing equivalents were primarily channeled for ATP generation and biomass synthesis that 267 are thermodynamically favorable under aerobic conditions, and hence likely became limited 268 for decarboxylation to produce target alkenes. 269
However, during the stationary phase where glucose was not available, EcNN201 270 consumed a total amount of 407.45 ± 22.19 mg/L FAs for not only cell maintenance but also 271 terminal alkene production. The terminal alkene production was increased up to 58% higher 272 during the stationary phase than the growth phase, underlying the critical functional role of the 273 redox system responsible for enhanced terminal alkene production. EcNN201 produced up to 274 49.64 ± 1.33 mg/L terminal alkenes, consisting of 0.7% ± 0.1% C11 alkene, 26.4% ± 2.6% 13 C13 alkene, 70.7% ± 3.0% C15 alkene, and 2.2% ± 0.4% C17 alkene. At 48 h, the alkene titer 276 and yield were 49.64 ± 1.33 mg/L and 2.44 ± 0.06 mg/g, respectively. In comparison to 277 EcNN101, the terminal alkene production of EcNN201 increased by 2.8 fold. It is interesting 278 to observe that C12:0-C14:0 FAs were primarily degraded for cell maintenance and C16:0 FA 279 utilized for alkene biosynthesis based on the FA distributions at 24 and 48 h ( Figure 5F ). This Figure S8 ). Because the current terminal alkene production in 296 EcNN201 is very inefficient, improving carbon and electron fluxes via metabolic engineering 297 is critical for enhanced terminal alkene production in future study. In addition, controlling 298 environmental conditions (e.g., sufficient supply of oxygen and use of highly reduced
CONCLUSION
301
In this study, we discovered and characterized a novel P450 FA decarboxylase OleTMC for 302 H2O2-independent biosynthesis of odd-chain, terminal alkenes. By combining the homology 303 modeling, in silico residue mutation analysis, and docking simulation with direct experimental 304 evidence, we elucidated the underlying mechanism that determines the substrate preferences 305 of OleTMC. In addition, we demonstrated the direct biosynthesis of medium-and long-chain 306 terminal alkenes in an engineered E. coli from fermentable sugars, abundant from 307 lignocellulosic biomass. We found that the inefficient electron transfer in OleTMC was the rate 308 limiting step that could be overcome by introducing a two-component redox system. Our 309 results help lay out a foundation for future study to modulate fatty acid thioesterases and OleTM 310 specificities to produce designer terminal alkenes with desirable carbon chain characteristics. 311
Overall, this study provides a better understanding of the novel functions of FA decarboxylases 312 and helps guide future protein and metabolic engineering for enhanced terminal alkene 313 production in a recombinant host. 314 315 Table 1 shows a list of bacterial strains and plasmids used in this study. E. coli TOP10 was 318 used for molecular cloning while BL21 (DE3) was employed as an expression and 319 characterization host. All plasmids were constructed by using a modified pETite* (30), a 320 derivative of pETite C-His backbone vector (Lucigen Corp., WI, USA), suitable for the 321 BglBricks gene assembly method (31). Primers used to construct the plasmids in this study are 322 listed in Table 2 . 323
MATERIALS AND METHODS
To construct the plasmid pCT71, the leaderless tesA* was amplified from the genomic 324 DNA of E. coli MG1655 using the primers mw.24f/p064_r, and inserted into pETite* via the removed to keep the encoded protein TesA* localized in the cytosol (32). The plasmid pNN33 327 was constructed by the Gibson gene assembly method (33) using 2 DNA fragments: i) the 328 decarboxylase gene OleTMC amplified from the genomic DNA of M. caseolyticus using the 329 primers Nhis6_OleTMCF/Nhis6_OleTMCR and ii) the backbone fragment amplified from 330 pETite* using the primers pnn33_Nhis6F/pnn33_Nhis6R. To construct the plasmid pNN32, 331
OleTMC was amplified using the primers mc_decarbF/rev_decarb and inserted into pCT71 via 332 the BamHI/XhoI sites. The plasmid pNN34 was constructed by the Gibson gene assembly 333 method using 3 DNA fragments: i) camA gene amplified from the genomic DNA of P. putida 334 using the primers pnn82/pnn83, ii) camB amplified from the genomic DNA of P. putida using 335 the primers pnn84/pnn85, and iii) the backbone fragment amplified from pETite* using the 336 primers pETiteF/pETiteR. All plasmid constructs were confirmed by enzyme digestion, PCR 337 amplification of the respective genes, and sequencing. 338
The strain EcNN101 was generated by introducing pNN32 into BL21 (DE3) via 339 electroporation. Similarly, the strain EcNN201 was created by co-transforming pNN32 and 340 pNN34 into BL21 (DE3). 341 342
Medium and strain characterization 343
Medium. For molecular cloning and protein expression, Luria-Bertani (LB) medium 344 containing 5 g/L yeast extract, 10 g/L tryptone, 5 g/L NaCl, and antibiotics (if applicable) was 345 used for E. coli and P. putida cultures. The medium for cultivating M. caseolyticus was 346 comprised of 5 g/L glucose, 5 g/L yeast extract, 10 g/L casein peptone, and 5 g/L NaCl. The to analyze 1 μL of samples. The column temperature was initially held at 50°C for 1 min, 419 increased by 20°C/min until 300°C, and held for 2 min. Helium was used as a carrier gas and 420 run at 1 mL/min. The mass transfer line and ion source were set at 250°C and 200°C, 421 respectively. 422
Bioinformatics 424
For sequence alignment and phylogenetic analysis, protein sequences were retrieved from the 425 National Center for Biotechnology Information (NCBI), and were inputted into MEGA7 (41) 426 and aligned via MUSCLE (42). The phylogenetic tree was generated using the neighbor-joining 427 algorithm with a 1000 bootstrap value. BLASTp was used to calculate the identity of sequences 428 (43) using OleTJE as the template. 429 In silico mutation analysis. The "alanine scan" and the "residue scan" tools in MOE 460 were used for in silico mutation analysis of FA-OleTMC complexes. Specifically, the alanine 461 scanning technique (47, 48) was employed to determine the importance of a specific residue to 462 the stability, affinity, and/or property of the FA-OleTMC complexes upon being substituted with GCG GAC ACG TTA TTG ATT CT  p064_r  AAA AAA CTC GAG TTA GGA TCC TTA TGA GTC ATG ATT  TAC TAA AG  Nhis6_OleTMCF  AGA AGG AGA TAT ACA TAT GCA TCA TCA CCA CCA TCA  CAG TAA AAG AGT TCC TAA AGA TAG  Nhis6_OleTMCR GTT ATG CTA GTT ATT GCT CAG CGG TGG CGG CCG CTC TAT TAT TTT GTA CGG TCG ATA TTC pnn33_Nhis6F
TAA TAG AGC GGC CGC CAC pnn33_Nhis6R GTG ATG GTG GTG ATG ATG CAT ATG TAT ATC TCC TTC TTA TAG TTA AAC AAA ATT AT mc_DecarbF ATG GAT CCA AAA ATG AGG GTA GAG TTT ACT ATT AA rev- Decarb  ATC TCG AGT TAT TTT GTA CGG TCG ATA TTC ACC CT  pnn82  ATA ATT TTG TTT AAC TAT AAG AAG GAG ATA TAC ATA  TGA ACG CAA ACG ACA ACG TGG TC  pnn83  GAC ACA TAC ACT ACT TTA GAC ATT TAT ATC TCC TTT  CAG GCA CTA CTC AGT TCA GCT TT  pnn84  AAA GCT GAA CTG AGT AGT GCC TGA AAG GAG ATA TAA  ATG TCT AAA GTA GTG TAT GTG TC  pnn85  GTG ATG ATG CTC GAG TTA GGA TCC TTA CCA TTG CCT  ATC GGG AAC ATC  pETiteF  GGA TCC TAA CTC GAG CAT CAT CAC CAC CAT CAC TA  pETiteR  TAT ATC TCC TTC TTA TAG TTA AAC AAA ATT ATT TC  611 612 613 
